Alzheimer’s Disease With Agitation Research Study
Alzheimer’s disease is a brain disorder that slowly destroys memory and thinking skills, and, eventually, the ability to carry out the simplest tasks. In most people with Alzheimer’s, symptoms first appear later in life. Estimates vary, but experts suggest that more than 6 million Americans may have dementia caused by Alzheimer’s.
Agitation is a common and challenging symptom of Alzheimer's disease that can include restlessness, worry, pacing, or aggression. It can be a direct result of the disease and can be caused by physical changes in the brain, or as an expression of anxiety or frustration about the condition. Agitation can also be triggered by changes in routine, surroundings, or caregivers, or by fear or fatigue.
That’s why ClinCloud is looking for participants for research on an investigational study drug that may help people with Alzheimer’s disease. To qualify, your loved one must:
- Be 40+ years of age
- Have agitation from Alzheimer’s disease
- Have a caregiver or study partner who spends 10 or more hours a week with participant
Qualified participants will receive study-related medication and care. Compensation for time and travel may be available. To learn more or schedule an appointment, complete the form below!
Does your loved one have Alzheimer’s with agitation?
It's never too early to take action.
Here are some of the early signs to look out for...
Pacing
Irritability
Sleeplessness
Being Confused About Time or Place
Anxiety
Verbal or Physical Lashing Out
Agitation
Loss of Inhibition
Suspicious
Ready to Make a Difference in Alzheimer’s Research?
Contact us today to learn more about our ongoing clinical trials and how you can contribute to finding a cure for Alzheimer's disease. Your participation matters, and together, we can bring hope to those affected by this condition. Complete the form below for yourself or a loved one today!
Alzheimer’s Disease With Agitation Study Form
Frequently Asked Questions
- Access to Cutting-Edge Treatments: Participants in ClinCloud’s Alzheimer’s disease clinical trials have the opportunity to access the latest investigational treatments and therapies that are not yet available to the general public.
- Expert Medical Care: Our team of skilled healthcare professionals, including doctors, nurses, and researchers, provides comprehensive medical care and support throughout the duration of the study.
- Contribute to Scientific Advancements: By participating in our research studies, you are contributing valuable data that can help scientists and researchers better understand Alzheimer's disease and develop more effective treatments.
- Financial Assistance: Some studies offer compensation for participation, which can help offset the costs associated with your involvement, such as travel and time away from work.
Participating in an Alzheimer's disease research study is a simple and straightforward process:
- Contact Us: Reach out to our dedicated team to express your interest in participating in a specific study or to learn more about our ongoing research projects for yourself or a loved one.
- Screening: ClinCloud’s healthcare professionals will conduct a thorough evaluation to determine eligibility for the selected Alzheimer’s disease study.
- Informed Consent: If you or your loved one qualify, you will receive detailed information about the study, and our team will guide you through the informed consent process.
- Participation: Once you provide your consent, you will begin your participation in the study under the supervision of our experienced medical staff.